News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Zealand Drug Discovery Firm Proacta Gets $8.2 Million First Venture Round



10/19/2005 5:09:00 PM

Proacta Inc., an oncology drug discovery company focusing on novel therapies for hypoxic, or oxygen-starved, tumors, has raised NZ$12.5 million ($8.2 million) in its Series A round of venture capital.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES